Search - tctmd.com

Displaying 201 - 220 of 372

Sort: Relevancy | Date

News Daily News

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

December 10, 2013

News Daily News

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

December 08, 2013

News Daily News

El Guiado mediante IVUS Reduce la Trombosis del STENT y los MACE comparado con la Angiografía

December 08, 2013

News Daily News

Registry: Closure Devices Reduce Vascular Complications After Transfemoral PCI

November 21, 2013

News Daily News

Registro: Los Dispositivos de Cierre Reducen las Complicaciones Vasculares tras PCI Transfemorales

November 21, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

Transfemoral Access (Plus Bivalirudin and Vascular Closure Devices) Provides Optimal Results!

Presenter: Sorin Brener

October 31, 2013

Presentation TCT 2013

I'm Not So Sure: Bivalirudin Plus a Potent Oral ADP Antagonist Is All You Need!

Presenter: Frederick Feit

October 31, 2013

Presentation TCT 2013

EURO MAXX: Perspectives on Bivalirudin in STEMI

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

Upstream Bivalirudin: Insights from EuroMax

Presenter: Philippe Gabriel Steg

October 30, 2013

Presentation TCT 2013

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Presenter: Philippe Gabriel Steg

October 30, 2013

News Industry News

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

October 30, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

Presentation TCT 2013

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Presenter: Sundeep Adusumalli

October 29, 2013

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

Presentation

HORIZONS-AMI: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding

Presenter: Gregg W. Stone

October 16, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Caitlin E. Cox

October 11, 2013

News Daily News

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

L.A. McKeown

October 04, 2013

Advertisement

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

El Guiado mediante IVUS Reduce la Trombosis del STENT y los MACE comparado con la Angiografía

Registry: Closure Devices Reduce Vascular Complications After Transfemoral PCI

Registro: Los Dispositivos de Cierre Reducen las Complicaciones Vasculares tras PCI Transfemorales

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Transfemoral Access (Plus Bivalirudin and Vascular Closure Devices) Provides Optimal Results!

I'm Not So Sure: Bivalirudin Plus a Potent Oral ADP Antagonist Is All You Need!

EURO MAXX: Perspectives on Bivalirudin in STEMI

Upstream Bivalirudin: Insights from EuroMax

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

HORIZONS-AMI: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content